$CYJBF

Hiab Corp (CYJBF) reported Q3 2026 organic sales growth of 5%, with comparable operating profit rising 73% to EUR69 million. Cash flow was EUR98 million, and the EVS acquisition contributed to orders and sales. However, organic orders fell 4%, and Americas orders dropped 15% due to market softness. ROCE declined to 20.2%, and EVS profitability was lower due to production stoppages. The company expects synergies of over EUR12 million by 2029.